首页> 外文期刊>Frontiers in Medicine >Serum Concentration of the Phytohormone Abscisic Acid Is Associated With Immune-Regulatory Mediators and Is a Potential Biomarker of Disease Severity in Chronic Obstructive Pulmonary Disease
【24h】

Serum Concentration of the Phytohormone Abscisic Acid Is Associated With Immune-Regulatory Mediators and Is a Potential Biomarker of Disease Severity in Chronic Obstructive Pulmonary Disease

机译:植物激素脱落酸的血清浓度与免疫调节介质有关,是慢性阻塞性肺病中疾病严重程度的潜在生物标志物

获取原文
获取外文期刊封面目录资料

摘要

COPD and asthma are two distinct but sometimes overlapping diseases exhibiting varying degrees and types of inflammation on different stages of the disease. Although several biomarkers are defined to estimate the inflammatory endotype and stages in these diseases, there is still a need for new markers and potential therapeutic targets. We investigated the levels of a phytohormone, abscisic acid (ABA) and its receptor, LANCL2, in COPD patients and asthmatics. In addition, PPAR-γ that is activated by ABA in a ligand-binding domain-independent manner was also included in the study. In this study, we correlated ABA with COPD-propagating factors to define the possible role of ABA, in terms of immune regulation, inflammation, and disease stages. We collected blood from 101 COPD patients, 52 asthmatics, and 57 controls. Bronchoscopy was performed on five COPD patients and 29 controls. We employed (i) liquid chromatography–tandem mass spectrometry and HPLC to determine the ABA and indoleamine 2,3-dioxygenase levels, respectively; (ii) real-time PCR to quantify the gene expression of LANCL2 and PPAR-γ; (iii) Flow cytometry to quantify adipocytokines; and (iv) immunoturbidimetry and ELISA to measure CRP and cytokines, respectively. Finally, a multinomial regression model was used to predict the probability of using ABA as a biomarker. Blood ABA levels were significantly reduced in COPD patients and asthmatics compared to age- and gender-matched normal controls. However, PPAR-γ was elevated in COPD patients. Intriguingly, ABA was positively correlated with immune-regulatory factors and was negatively correlated with inflammatory markers, in COPD. Of note, ABA was increased in advanced COPD stages. We thereby conclude that ABA might be involved in regulation of COPD pathogenesis and might be regarded as a potential biomarker for COPD stages.
机译:COPD和哮喘是两个不同的,但有时重叠的疾病表现出不同程度和疾病的不同阶段的炎症。虽然定义了几种生物标志物估计这些疾病中的炎症内型和阶段,但仍然需要新的标记和潜在的治疗目标。我们研究了植物激素,脱盐酸(ABA)及其受体,LANCL2,COPD患者和哮喘学的水平。此外,在研究中,ABA激活的PPAR-γ还包括在研究中的邻立型结构域的互相型方式。在这项研究中,我们将ABA与COPD繁殖因素相关联,以确定ABA的可能作用,在免疫调节,炎症和疾病阶段。我们收集了来自101名COPD患者,52名哮喘和57个对照的血液。在五个COPD患者和29例对照中进行支气管镜检查。我们使用(i)液相色谱 - 串联质谱和HPLC分别测定ABA和吲哚胺2,3-二氧化根酶水平; (ii)实时PCR量化LANCL2和PPAR-γ的基因表达; (iii)流式细胞术量化脂肪细胞因子; (IV)免疫浊和ELISA分别测量CRP和细胞因子。最后,使用多项回归模型来预测使用ABA作为生物标志物的可能性。与年龄和性别匹配的正常对照相比,COPD患者和哮喘的血液ABA水平显着降低。然而,PPAR-γ在COPD患者中升高。有趣的是,ABA与免疫调节因子呈正相关,并与COPD中的炎症标志物呈负相关。值得注意的是,ABA在高级COPD阶段增加。因此,我们得出结论,ABA可能参与调节COPD发病机制,并且可能被视为COPD阶段的潜在生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号